The Journal of Experimental Medicine
PBL InterferonSource
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online February 18, 2008
doi:10.1084/jem.20071477
The Journal of Experimental Medicine, Vol. 205, No. 3, 565-574
The Rockefeller University Press, 0022-1007 $30.00
© 2008 Haxhinasto et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Haxhinasto, S.
Right arrow Articles by Benoist, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haxhinasto, S.
Right arrow Articles by Benoist, C.
Related Collections
Right arrowRelated In this Issue article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

The AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells

Sokol Haxhinasto1,2, Diane Mathis1,2, and Christophe Benoist1,2

1 Section on Immunology and Immunogenetics, Joslin Diabetes Center and 2 Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215

CORRESPONDENCE Diane Mathis OR Christophe Benoist: cbdm{at}joslin.harvard.edu

CD4+Foxp3+ regulatory T (T reg) cells play an essential role in maintaining immunological tolerance via their suppressive function on conventional CD4+ T (Tconv) cells. Repertoire studies suggest that distinct T cell receptor signaling pathways lead to T reg differentiation, but the signals that regulate T reg specification are largely unknown. We identify AKT as a strong repressor of entry into the T reg phenotype in vitro and in vivo. A constitutively active allele of AKT substantially diminished TGF-β–induced Foxp3 expression in a kinase-dependent manner and via a rapamycin-sensitive pathway, implicating the AKT–mammalian target of rapamycin axis. The observed impairment in Foxp3 induction was part of a broad dampening of the typical T reg transcriptional signature. Expression of active AKT at a stage before Foxp3 turn on during normal T reg differentiation in the thymus selectively impaired differentiation of CD4+Foxp3+ cells without any alteration in the positive selection of Tconv. Activated AKT, in contrast, did not affect established Foxp3 expression in T reg cells. These results place AKT at a nexus of signaling pathways whose proper activation has a strong and broad impact on the onset of T reg specification.


Abbreviations used: AKT*, constitutively active AKT; CTRL, control; DN, double negative; DP, double positive; mTOR, mammalian target of rapamycin; PI3K, phosphoinositide 3-kinase; SP, single positive; Tconv cell, conventional CD4+ T cell.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related In this Issue article

Regulatory T cell brakes
Hema Bashyam
J. Exp. Med. 2008 205: 505. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS